Cargando…
Drug resistance mechanisms and progress in the treatment of EGFR-mutated lung adenocarcinoma
According to global cancer data, lung cancer was the leading cause of cancer-related death in 2020. With the diversification of treatment strategies, the survival outcomes of patients with advanced lung cancer have improved significantly, but the 5-year overall survival rate remains <20%. Epiderm...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555020/ https://www.ncbi.nlm.nih.gov/pubmed/36245822 http://dx.doi.org/10.3892/ol.2022.13528 |